{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:14:19Z","timestamp":1789600459934,"version":"build-2803163510"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000264","name":"Canadian Liver Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.pharmthera.2019.05.004","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T22:23:34Z","timestamp":1557267814000},"page":"179-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Primary aromatic amines and cancer: Novel mechanistic insights using 4-aminobiphenyl as a model carcinogen"],"prefix":"10.1016","volume":"200","author":[{"given":"Shuang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim S.","family":"Sugamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis M.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.pharmthera.2019.05.004_bb0005","first-page":"826","article-title":"Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro","volume":"1","author":"Adam","year":"2003","journal-title":"Molecular Cancer Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.05.004_bb0010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0021-9673(99)00779-7","article-title":"Analysis of DNA adducts using high-performance separation techniques coupled to electrospray ionization mass spectrometry","volume":"856","author":"Andrews","year":"1999","journal-title":"Journal of Chromatography A"},{"issue":"10","key":"10.1016\/j.pharmthera.2019.05.004_bb0015","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/carcin\/1.10.877","article-title":"Correlation of nucleic acid binding by metabolites of trans-4-aminostilbene derivatives with tissue specific acute toxicity and carcinogenicity in rats","volume":"1","author":"Baur","year":"1980","journal-title":"Carcinogenesis"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2019.05.004_bb0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00296956","article-title":"The oxidation of isomeric amino and acetamidobiphenyls by rat hepatic microsomal preparations","volume":"60","author":"Bayraktar","year":"1987","journal-title":"Archives of Toxicology"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2019.05.004_bb0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mrfmmm.2009.08.003","article-title":"Differences between human slow N-acetyltransferase 2 alleles in levels of 4-aminobiphenyl-induced DNA adducts and mutations","volume":"671","author":"Bendaly","year":"2009","journal-title":"Mutation Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.05.004_bb0030","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1096\/fj.12-227074","article-title":"Genotoxicity of tobacco smoke-derived aromatic amines and bladder cancer: Current state of knowledge and future research directions","volume":"27","author":"Besaratinia","year":"2013","journal-title":"The FASEB Journal"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.05.004_bb0035","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1042\/bj0910362","article-title":"The biochemistry of aromatic amines. 10. Enzymic N-hydroxylation of arylamines and conversion of arylhydroxylamines into o-aminophenols","volume":"91","author":"Booth","year":"1964","journal-title":"Biochemical Journal"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.05.004_bb0040","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00008571-200207000-00006","article-title":"Identification and functional characterization of novel polymorphisms associated with the genes for arylamine N-acetyltransferases in mice","volume":"12","author":"Boukouvala","year":"2002","journal-title":"Pharmacogenetics"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.05.004_bb0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1124\/pr.110.004275","article-title":"Arylamine N-acetyltransferase 1: A novel drug target in cancer development","volume":"64","author":"Butcher","year":"2012","journal-title":"Pharmacological Reviews"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.05.004_bb0050","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.96.5.1977","article-title":"Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas","volume":"96","author":"Buters","year":"1999","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.05.004_bb0055","first-page":"25","article-title":"Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4\u2032-methylene-bis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases","volume":"49","author":"Butler","year":"1989","journal-title":"Cancer Research"},{"issue":"20","key":"10.1016\/j.pharmthera.2019.05.004_bb0060","doi-asserted-by":"crossref","first-page":"7696","DOI":"10.1073\/pnas.86.20.7696","article-title":"Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines","volume":"86","author":"Butler","year":"1989","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"52","key":"10.1016\/j.pharmthera.2019.05.004_bb0065","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1716990115","article-title":"Mechanism by which arylamine N-acetyltransferase 1 ablation causes insulin resistance in mice","volume":"114","author":"Camporez","year":"2017","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.05.004_bb0070","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1002\/mc.22869","article-title":"Knockout of human arylamine N-acetyltransferase 1 (NAT1) in MDA-MB-231 breast cancer cells leads to increased reserve capacity, maximum mitochondrial capacity, and glycolytic reserve capacity","volume":"57","author":"Carlisle","year":"2018","journal-title":"Molecular Carcinogenesis"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.05.004_bb0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev.pharmtox.44.101802.121704","article-title":"Oxidative stress, toxicology, and pharmacology of CYP2E1","volume":"44","author":"Caro","year":"2004","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.05.004_bb0080","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/jat.3046","article-title":"Protective effects of ascorbic acid against the genetic and epigenetic alterations induced by 3,5-dimethylaminophenol in AA8 cells","volume":"35","author":"Chao","year":"2015","journal-title":"Journal of Applied Toxicology"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.05.004_bb0085","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/toxsci\/kfy306","article-title":"In vitro and in vivo analysis of the effects of 3,5-DMA and its metabolites in neural oxidative stress and neurodevelopmental toxicity","volume":"168","author":"Chao","year":"2018","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.pharmthera.2019.05.004_bb0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jchromb.2018.04.041","article-title":"Recent technical and biological development in the analysis of biomarker N-deoxyguanosine-C8-4-aminobiphenyl","volume":"1087-1088","author":"Chen","year":"2018","journal-title":"Journal of Chromatography B"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.05.004_bb0095","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.celrep.2016.09.005","article-title":"Nat1 deficiency is associated with mitochondrial dysfunction and exercise intolerance in mice","volume":"17","author":"Chennamsetty","year":"2016","journal-title":"Cell Reports"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.05.004_bb0100","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1021\/tx050136g","article-title":"Differential metabolism of 2-amino-1-methyl-6-phenylimidazo4,5-[b]pyridine (PhIP) in mice humanized for CYP1A1 and CYP1A2","volume":"18","author":"Cheung","year":"2005","journal-title":"Chemical Research in Toxicology"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.05.004_bb0105","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/carcin\/16.2.413","article-title":"Metabolic activation of the N-hydroxy derivative of the carcinogen 4-aminobiphenyl by human tissue sulfotransferases","volume":"16","author":"Chou","year":"1995","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.05.004_bb0110","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/sj.tpj.6500170","article-title":"Generation and analysis of mice with a targeted disruption of the arylamine N-acetyltransferase type 2 gene","volume":"3","author":"Cornish","year":"2003","journal-title":"The Pharmacogenomics Journal"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.05.004_bb0115","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0021-9258(19)67954-8","article-title":"N-hydroxylation: A new metabolic reaction bserved in the rat with the carcinogen 2-acetylaminofluorene","volume":"235","author":"Cramer","year":"1960","journal-title":"Journal of Biological Chemistry"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.05.004_bb0120","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/carcin\/16.9.2135","article-title":"Early formation of DNA adducts compared with tumor formation in a long-term tumor study in rats after administration of 2-nitrofluorene","volume":"16","author":"Cui","year":"1995","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.05.004_bb0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s003450100211","article-title":"Ludwig Rehn (1849-1930)--pioneering findings on the aetiology of bladder tumours","volume":"19","author":"Dietrich","year":"2001","journal-title":"World Journal of Urology"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.05.004_bb0130","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1124\/jpet.110.168567","article-title":"Codominant expression of N-acetylation and O-acetylation activities catalyzed by N-acetyltransferase 2 in human hepatocytes","volume":"334","author":"Doll","year":"2010","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.05.004_bb0135","first-page":"1172","article-title":"Local carcinogenicity, rates of absorption, extent and persistence of macromolecular binding, and acute histopathological effects of N-hydroxy-1-naphthylamine and N-hydroxy-2-naphthylamine","volume":"44","author":"Dooley","year":"1984","journal-title":"Cancer Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.05.004_bb0140","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0165-1218(81)90057-4","article-title":"Effects of ortho-methyl substituents on the mutagenicity of aminobiphenyls and aminonaphthalenes","volume":"90","author":"El-Bayoumy","year":"1981","journal-title":"Mutation Research\/Genetic Toxicology"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.05.004_bb0145","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/carcin\/7.6.919","article-title":"Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2\u2032-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent acyltransferases","volume":"7","author":"Flammang","year":"1986","journal-title":"Carcinogenesis"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.05.004_bb0150","first-page":"1977","article-title":"Arachidonic acid-dependent peroxidative activation of carcinogenic arylamines by extrahepatic human tissue microsomes","volume":"49","author":"Flammang","year":"1989","journal-title":"Cancer Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.05.004_bb0155","first-page":"2671","article-title":"Cytochrome P-450- and flavin-containing monooxygenase-catalyzed formation of the carcinogen N-hydroxy-2-aminofluorene and its covalent binding to nuclear DNA","volume":"42","author":"Frederick","year":"1982","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.05.004_bb0160","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1006\/taap.1996.8036","article-title":"Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H\/HeJ (rapid) and a\/HeJ (slow) acetylator inbred mouse: Functional characterization of the activation and deactivation of aromatic amine carcinogens","volume":"142","author":"Fretland","year":"1997","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.05.004_bb0165","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1124\/dmd.106.011064","article-title":"CYP2A13 metabolizes the substrates of human CYP1A2, phenacetin, and theophylline","volume":"35","author":"Fukami","year":"2007","journal-title":"Drug Metabolism and Disposition"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.05.004_bb0170","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0304-3835(99)00125-1","article-title":"Role of gene knockout mice in understanding the mechanisms of chemical toxicity and carcinogenesis","volume":"143","author":"Gonzalez","year":"1999","journal-title":"Cancer Letters"},{"issue":"20","key":"10.1016\/j.pharmthera.2019.05.004_bb0175","doi-asserted-by":"crossref","first-page":"7971","DOI":"10.1073\/pnas.86.20.7971","article-title":"Efficient rescue of integrated shuttle vectors from transgenic mice: A model for studying mutations in vivo","volume":"86","author":"Gossen","year":"1989","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.05.004_bb0180","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1021\/acs.chemrestox.8b00268","article-title":"Targeted and untargeted detection of DNA adducts of aromatic amine carcinogens in human bladder by ultra-performance liquid chromatography-high-resolution mass spectrometry","volume":"31","author":"Guo","year":"2018","journal-title":"Chemical Research in Toxicology"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.05.004_bb0185","first-page":"3578","article-title":"Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic microsomes and by purified flavin-containing and cytochrome P-450 monooxygenases","volume":"45","author":"Hammons","year":"1985","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2019.05.004_bb0190","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4061\/2010\/709521","article-title":"Formation and repair of tobacco carcinogen-derived bulky DNA adducts","volume":"2010","author":"Hang","year":"2010","journal-title":"Journal of Nucleic Acids"},{"key":"10.1016\/j.pharmthera.2019.05.004_bb0195","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tox.2016.10.006","article-title":"Influence of sex and developmental stage on acute hepatotoxic and inflammatory responses to liver procarcinogens in the mouse","volume":"373","author":"Hanna","year":"2016","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.05.004_bb0200","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1039\/C7TX00020K","article-title":"Toxicological implications of mitochondrial localization of CYP2E1","volume":"6","author":"Hartman","year":"2017","journal-title":"Toxicology Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.05.004_bb0205","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0165-1110(94)90025-6","article-title":"Genetic toxicity of 2-acetylaminofluorene, 2-aminofluorene and some of their metabolites and model metabolites","volume":"318","author":"Heflich","year":"1994","journal-title":"Mutation Research\/Reviews in Genetic Toxicology"},{"key":"10.1016\/j.pharmthera.2019.05.004_bb0210","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0027-5107(02)00153-7","article-title":"Molecular genetics and function of NAT1 and NAT2: Role in aromatic amine metabolism and carcinogenesis","volume":"506-507","author":"Hein","year":"2002","journal-title":"Mutation Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.05.004_bb0215","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0027-5107(97)00031-6","article-title":"Rodent models of the human acetylation polymorphism: Comparisons of recombinant acetyltransferases","volume":"376","author":"Hein","year":"1997","journal-title":"Mutation Research\/Fundamental and Molecular Mechanisms of Mutagenesis"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.05.004_bb0220","first-page":"29","article-title":"Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms","volume":"9","author":"Hein","year":"2000","journal-title":"Cancer Epidemiology Biomarkers & Prevention"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.05.004_bb0225","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/carcin\/14.8.1633","article-title":"Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases","volume":"14","author":"Hein","year":"1993","journal-title":"Carcinogenesis"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.05.004_bb0230","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/carcin\/4.12.1519","article-title":"The role of partial hepatectomy and of promoters in the formation of tumors in non-target tissues of trans-4-acetylaminostilbene in rats","volume":"4","author":"Hilpert","year":"1983","journal-title":"Carcinogenesis"},{"issue":"48","key":"10.1016\/j.pharmthera.2019.05.004_bb0235","doi-asserted-by":"crossref","first-page":"50280","DOI":"10.1074\/jbc.M409224200","article-title":"Observing translesion synthesis of an aromatic amine DNA adduct by a high-fidelity DNA polymerase","volume":"279","author":"Hsu","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.05.004_bb0240","first-page":"46","article-title":"Experimental production of bladder tumors in dogs by administration of beta-naphthylamine","author":"Hueper","year":"1937","journal-title":"Journal of Industrial Hygiene"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.05.004_bb0245","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/carcin\/10.8.1403","article-title":"A rationale for the non-mutagenicity of 2- and 3-aminobiphenyls","volume":"10","author":"Ioannides","year":"1989","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.pharmthera.2019.05.004_bb0250","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2741\/S376","article-title":"Reactive electrophilic metabolites of aromatic amine and amide carcinogens","volume":"5","author":"Josephy","year":"2013","journal-title":"Frontiers in Bioscience"},{"issue":"16","key":"10.1016\/j.pharmthera.2019.05.004_bb0255","first-page":"4371","article-title":"Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl","volume":"51","author":"Kadlubar","year":"1991","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2019.05.004_bb0260","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1289\/ehp.9087233","article-title":"The metabolic N-oxidation of carcinogenic arylamines in relation to nitrogen charge density and oxidation potential","volume":"87","author":"Kadlubar","year":"1990","journal-title":"Environmental Health Perspectives"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.05.004_bb0265","first-page":"805","article-title":"Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis","volume":"37","author":"Kadlubar","year":"1977","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.05.004_bb0270","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/carcin\/1.2.139","article-title":"In vitro reaction of the carcinogen, N-hydroxy-2-naphthylamine, with DNA at the C-8 and N2 atoms of guanine and at the N6 atom of adenine","volume":"1","author":"Kadlubar","year":"1980","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.05.004_bb0275","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0026-895X(25)14392-7","article-title":"A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Catalytic characterization and immunochemical quantitation in liver microsomes","volume":"24","author":"Kamataki","year":"1983","journal-title":"Molecular Pharmacology"},{"issue":"Pt 2","key":"10.1016\/j.pharmthera.2019.05.004_bb0280","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1042\/bj3020347","article-title":"Arylamine N-acetyltransferase in Balb\/c mice: Identification of a novel mouse isoenzyme by cloning and expression in vitro","volume":"302","author":"Kelly","year":"1994","journal-title":"The Biochemical Journal"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2019.05.004_bb0285","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0378-4274(93)90047-2","article-title":"Reactivity and genotoxicity of arylnitrenium ions in bacterial and mammalian cells","volume":"67","author":"Kerdar","year":"1993","journal-title":"Toxicology Letters"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.05.004_bb0290","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev.pharmtox.45.120403.100010","article-title":"Cytochrome P450 activation of arylamines and heterocyclic amines","volume":"45","author":"Kim","year":"2005","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.05.004_bb0295","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/carcin\/20.9.1825","article-title":"CYP1A2 is not the primary enzyme responsible for 4-aminobiphenyl-induced hepatocarcinogenesis in mice","volume":"20","author":"Kimura","year":"1999","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.05.004_bb0300","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/carcin\/24.3.583","article-title":"Carcinogenesis of the food mutagen PhIP in mice is independent of CYP1A2","volume":"24","author":"Kimura","year":"2003","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.05.004_bb0305","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0014-5793(96)00592-3","article-title":"2-Nitrosofluorene and N-hydroxy-2-aminofluorene react with the ubiquinone-reduction center (center N) of the mitochondrial cytochrome bc1 complex","volume":"389","author":"Kl\u00f6hn","year":"1996","journal-title":"FEBS Letters"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.05.004_bb0310","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0005-2728(95)00019-F","article-title":"A metabolite of carcinogenic 2-acetylaminofluorene, 2-nitrosofluorene, induces redox cycling in mitochondria","volume":"1229","author":"Klohn","year":"1995","journal-title":"Biochimica et Biophysica Acta"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.05.004_bb0315","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0009-2797(97)00052-5","article-title":"Impairment of respiration and oxidative phosphorylation by redox cyclers 2-nitrosofluorene and menadione","volume":"106","author":"Kl\u00f6hn","year":"1997","journal-title":"Chemico-Biological Interactions"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.05.004_bb0320","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1172\/JCI74692","article-title":"Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene","volume":"125","author":"Knowles","year":"2015","journal-title":"The Journal of Clinical Investigation"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.05.004_bb0325","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0090-9556(24)15234-8","article-title":"Involvement of CYP2E1 as a low-affinity enzyme in phenacetin O-deethylation in human liver microsomes","volume":"27","author":"Kobayashi","year":"1999","journal-title":"Drug Metabolism and Disposition"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.05.004_bb0330","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0009-2797(71)90023-8","article-title":"On the mechanism of action of carcinogenic aromatic amines","volume":"3","author":"Kriek","year":"1971","journal-title":"Chemico-Biological Interactions"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.05.004_bb0335","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/carcin\/6.9.1337","article-title":"Syncarcinogenic effects on the initiation of rat liver tumors by trans-4-acetylaminostilbene and 2-acetylaminofluorene","volume":"6","author":"Kuchlbauer","year":"1985","journal-title":"Carcinogenesis"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.05.004_bb0340","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/carcin\/9.7.1295","article-title":"The essential role of microsomal deacetylase activity in the metabolic activation, DNA-(deoxyguanosin-8-yl)-2-aminofluorene adduct formation and initiation of liver tumors by N-hydroxy-2-acetylaminofluorene in the livers of infant male B6C3F1 mice","volume":"9","author":"Lai","year":"1988","journal-title":"Carcinogenesis"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.05.004_bb0345","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/carcin\/6.7.1037","article-title":"N-Sulfo\u00f6xy-2-aminofluorene is the major ultimate electrophilic and carcinogenic metabolite of N-hydroxy-2-acetylaminofluorene in the livers of infant male C57BL\/6J \u00d7 C3H\/HeJ F1 (B6C3F1) mice","volume":"6","author":"Lai","year":"1985","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.05.004_bb0350","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/carcin\/10.4.727","article-title":"Metabolism of aromatic amines: Relationships of N-acetylation, O-acetylation, N,O-acetyltransfer and deacetylation in human liver and urinary bladder","volume":"10","author":"Land","year":"1989","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.05.004_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096370","article-title":"From arylamine N-acetyltransferase to folate-dependent acetyl CoA hydrolase: Impact of folic acid on the activity of (HUMAN)NAT1 and its homologue (MOUSE)NAT2","volume":"9","author":"Laurieri","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.05.004_bb0360","first-page":"1029","article-title":"Die unter dem Einfluss der synthetischen Farbenindustrie beobachtete Geschwulstentwicklung","volume":"5","author":"Leuenberger","year":"1912","journal-title":"Beitr z klin chir"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.05.004_bb0365","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/carcin\/10.4.705","article-title":"2-Aminofluorene-DNA adduct formation in acetylator congenic mouse lines","volume":"10","author":"Levy","year":"1989","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.05.004_bb0370","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1124\/jpet.106.108662","article-title":"N-acetyltransferase (Nat) 1 and 2 expression in Nat2 knockout mice","volume":"319","author":"Loehle","year":"2006","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.05.004_bb0375","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1084\/jem.73.3.391","article-title":"The experimental discosure of latent neoplastic changes in tarred skin","volume":"73","author":"MacKenzie","year":"1941","journal-title":"The Journal of Experimental Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.05.004_bb0380","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/em.20288","article-title":"Evidence that 4-aminobiphenyl, benzidine, and benzidine congeners produce genotoxicity through reactive oxygen species","volume":"48","author":"Makena","year":"2007","journal-title":"Environmental and Molecular Mutagenesis"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.05.004_bb0385","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0026-895X(25)12944-1","article-title":"Molecular genetic basis of rapid and slow acetylation in mice","volume":"40","author":"Martell","year":"1991","journal-title":"Molecular Pharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.05.004_bb0390","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/17425255.2.6.875","article-title":"Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction","volume":"2","author":"Martignoni","year":"2006","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.05.004_bb0395","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0026-895X(25)11427-2","article-title":"Purification and biochemical characterization of hepatic arylamine N-acetyltransferase from rapid and slow acetylator mice: Identity with arylhydroxamic acid N,O-acyltransferase and N-hydroxyarylamine O-acetyltransferase","volume":"35","author":"Mattano","year":"1989","journal-title":"Molecular Pharmacology"},{"issue":"14","key":"10.1016\/j.pharmthera.2019.05.004_bb0400","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1021\/ja00119a035","article-title":"Electron-deficient strong bases. Generation of the 4-biphenylyl- and 2-fluorenylnitrenium ions by nitrene protonation in water","volume":"117","author":"McClelland","year":"1995","journal-title":"Journal of the American Chemical Society"},{"issue":"7\u20138","key":"10.1016\/j.pharmthera.2019.05.004_bb0405","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/00498258009033782","article-title":"The N-hydroxylation and ring-hydroxylation of 4-aminobiphenyl in vitro by hepatic mono-oxygenases from rat, mouse, hamster, rabbit and Guinea-pig","volume":"10","author":"McMahon","year":"1980","journal-title":"Xenobiotica"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.05.004_bb0410","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0003-2697(92)90363-C","article-title":"The quantitative analysis of endogenous folate catabolites in human urine","volume":"206","author":"McPartlin","year":"1992","journal-title":"Analytical Biochemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.05.004_bb0415","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0009-2797(03)00073-5","article-title":"The effects of genetic variation in N-acetyltransferases on 4-aminobiphenyl genotoxicity in mouse liver","volume":"146","author":"McQueen","year":"2003","journal-title":"Chemico-Biological Interactions"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.05.004_bb0420","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/carcin\/2.5.413","article-title":"Role of sulfation in the formation of DNA adducts from N-hydroxy-2-acetylaminofluorene in rat liver in vivo. Inhibition of N-acetylated aminofluorene adduct formation by penta-chlorophenol","volume":"2","author":"Meerman","year":"1981","journal-title":"Carcinogenesis"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.05.004_bb0425","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/mc.20836","article-title":"NATb\/NAT1*4 promotes greater arylamine N-acetyltransferase 1 mediated DNA adducts and mutations than NATa\/NAT1*4 following exposure to 4-aminobiphenyl","volume":"51","author":"Millner","year":"2012","journal-title":"Molecular Carcinogenesis"},{"issue":"Pt 1","key":"10.1016\/j.pharmthera.2019.05.004_bb0430","first-page":"1","article-title":"Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells","volume":"307","author":"Minchin","year":"1995","journal-title":"The Biochemical Journal"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.05.004_bb0435","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0006-291X(92)91703-S","article-title":"N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells","volume":"185","author":"Minchin","year":"1992","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"34","key":"10.1016\/j.pharmthera.2019.05.004_bb0440","doi-asserted-by":"crossref","first-page":"23963","DOI":"10.1074\/jbc.274.34.23963","article-title":"Targeted disruption of the microsomal epoxide hydrolase gene. Microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[a]anthracene","volume":"274","author":"Miyata","year":"1999","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.05.004_bb0445","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/carcin\/bgq223","article-title":"GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: Results from the New England bladder cancer study and NAT2 meta-analysis","volume":"32","author":"Moore","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.pharmthera.2019.05.004_bb0450","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.2741\/3739","article-title":"Mechanisms of oxidative DNA damage induced by carcinogenic arylamines","volume":"16","author":"Murata","year":"2011","journal-title":"Frontiers in Bioscience"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.05.004_bb0455","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0891-5849(01)00463-4","article-title":"Mechanism of oxidative DNA damage induced by carcinogenic 4-aminobiphenyl","volume":"30","author":"Murata","year":"2001","journal-title":"Free Radical Biology and Medicine"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.05.004_bb0460","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/ijc.22136","article-title":"CYP2A13 expressed in human bladder metabolically activates 4-aminobiphenyl","volume":"119","author":"Nakajima","year":"2006","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.pharmthera.2019.05.004_bb0465","author":"National Toxicology Program"},{"issue":"5834","key":"10.1016\/j.pharmthera.2019.05.004_bb0470","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.1140485","article-title":"Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production","volume":"317","author":"Naugler","year":"2007","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.05.004_bb0475","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00404390","article-title":"The role of DNA damage in chemical carcinogenesis of aromatic amines","volume":"112","author":"Neumann","year":"1986","journal-title":"Journal of Cancer Research and Cclinical Oncology"},{"issue":"21","key":"10.1016\/j.pharmthera.2019.05.004_bb0480","doi-asserted-by":"crossref","first-page":"9453","DOI":"10.1021\/ja00074a010","article-title":"Reactivity and selectivity of nitrenium ions derived from ester derivatives of carcinogenic N-(4-biphenylyl)hydroxylamine and the corresponding hydroxamic acid","volume":"115","author":"Novak","year":"1993","journal-title":"Journal of the American Chemical Society"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.05.004_bb0485","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/carcin\/15.3.489","article-title":"Consequences of 3-methylcholanthrene-type induction for the metabolism of 4-aminobiphenyl in isolated rat hepatocytes","volume":"15","author":"Orzechowski","year":"1994","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.05.004_bb0490","first-page":"1469","article-title":"DNA-damaging activity in vivo and bacterial mutagenicity of sixteen hydrazine derivatives as related quantitatively to their carcinogenicity","volume":"41","author":"Parodi","year":"1981","journal-title":"Cancer Research"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.05.004_bb0495","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/carcin\/2.12.1317","article-title":"DNA-damaging activity in vivo and bacterial mutagenicity of sixteen aromatic amines and azo-derivatives, as related quantitatively to their carcinogenicity","volume":"2","author":"Parodi","year":"1981","journal-title":"Carcinogenesis"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2019.05.004_bb0500","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0027-5107(83)90122-7","article-title":"Lack of correlation between the capability of inducing sister-chromatid exchanges in vivo and carcinogenic potency, for 16 aromatic amines and azo derivatives","volume":"108","author":"Parodi","year":"1983","journal-title":"Mutation Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.05.004_bb0505","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/mutage\/gei066","article-title":"Levels of H-ras codon 61 CAA to AAA mutation: Response to 4-ABP-treatment and Pms2-deficiency","volume":"21","author":"Parsons","year":"2005","journal-title":"Mutagenesis"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.05.004_bb0510","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1021\/acs.chemrestox.5b00418","article-title":"Methemoglobin formation and characterization of hemoglobin adducts of carcinogenic aromatic amines and heterocyclic aromatic amines","volume":"29","author":"Pathak","year":"2016","journal-title":"Chemical Research in Toxicology"},{"key":"10.1016\/j.pharmthera.2019.05.004_bb0515","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrc1410","article-title":"Chemical-induced DNA damage and human cancer risk","volume":"4","author":"Poirier","year":"2004","journal-title":"Nature Reviews Cancer"},{"issue":"Suppl. 6","key":"10.1016\/j.pharmthera.2019.05.004_bb0520","first-page":"161","article-title":"DNA adduct measurements and tumor incidence during chronic carcinogen exposure in rodents","volume":"102","author":"Poirier","year":"1994","journal-title":"Environmental Health Perspectives"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.05.004_bb0525","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/carcin\/12.5.895","article-title":"Comparison between DNA adduct formation and tumorigenesis in livers and bladders of mice chronically fed 2-acetylaminofluorene","volume":"12","author":"Poirier","year":"1991","journal-title":"Carcinogenesis"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.05.004_bb0530","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1093\/carcin\/16.12.2917","article-title":"DNA adduct formation and tumorigenesis in mice during the chronic administration of 4-aminobiphenyl at multiple dose levels","volume":"16","author":"Poirier","year":"1995","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.05.004_bb0535","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/carcin\/21.3.353","article-title":"Carcinogen macromolecular adducts and their measurement","volume":"21","author":"Poirier","year":"2000","journal-title":"Carcinogenesis."},{"issue":"6","key":"10.1016\/j.pharmthera.2019.05.004_bb0540","first-page":"1077","article-title":"Organ, species, and compound specificity in the metabolic activation of primary aromatic amines","volume":"70","author":"Poupko","year":"1983","journal-title":"The Journal of the National Cancer Institute"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.05.004_bb0545","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.pa.19.040179.001021","article-title":"The primary aromatic amines: Their biological properties and structure-activity relationships","volume":"19","author":"Radomski","year":"1979","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"10","key":"10.1016\/j.pharmthera.2019.05.004_bb0550","first-page":"3537","article-title":"Failure of pure 1-naphthylamine to induce bladder tumors in dogs","volume":"40","author":"Radomski","year":"1980","journal-title":"Cancer Research"},{"issue":"10","key":"10.1016\/j.pharmthera.2019.05.004_bb0555","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1073\/pnas.78.10.6126","article-title":"32P-labeling test for DNA damage","volume":"78","author":"Randerath","year":"1981","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.05.004_bb0560","first-page":"73","article-title":"Blasengeschwulste bei fuchsinarbeitern","volume":"39","author":"Rehn","year":"1895","journal-title":"Langenbecks archiv fur klinische chirurgie"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.05.004_bb0565","first-page":"356","article-title":"Liver tumor inhibition and adrenal histologic responses in rats to which 3\u2032-methyl-4-dimethylaminoazobenzene and 20-methylcholanthrene were simultaneously administered","volume":"12","author":"Richardson","year":"1952","journal-title":"Cancer Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.05.004_bb0570","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1084\/jem.73.3.365","article-title":"Conditional neoplasms and subthreshold neoplastic states: A study of the tar tumors of rabbits","volume":"73","author":"Rous","year":"1941","journal-title":"The Journal of Experimental Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.05.004_bb0575","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/carcin\/9.2.265","article-title":"Synergistic effects on the initiation of rat liver tumors by trans-4-acetylaminostilbene and 2-acetylaminofluorene, studied at the level of DNA adduct formation","volume":"9","author":"Ruthsatz","year":"1988","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.05.004_bb0580","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.taap.2005.11.003","article-title":"CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers","volume":"213","author":"Sarkar","year":"2006","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.05.004_bb0585","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0090-9556(25)06821-7","article-title":"Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey","volume":"23","author":"Sharer","year":"1995","journal-title":"Drug Metabolism and Disposition"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.05.004_bb0590","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/taap.2002.9398","article-title":"Decrease in 4-aminobiphenyl-induced methemoglobinemia in Cyp1a2(\u2212\/\u2212) knockout mice","volume":"181","author":"Shertzer","year":"2002","journal-title":"Toxicololgy and Applied Pharmacology"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.05.004_bb0595","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1111\/bph.12598","article-title":"Arylamine N-acetyltransferases: From drug metabolism and pharmacogenetics to drug discovery","volume":"171","author":"Sim","year":"2014","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.05.004_bb0600","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1081\/DMR-120005657","article-title":"N-oxidation of aromatic amines by intracellular oxidases","volume":"34","author":"Siraki","year":"2002","journal-title":"Drug Metabolism Reviews"},{"issue":"10","key":"10.1016\/j.pharmthera.2019.05.004_bb0605","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0278-6915(02)00110-2","article-title":"Effect of CYP1A2 deficiency on heterocyclic amine DNA adduct levels in mice","volume":"40","author":"Snyderwine","year":"2002","journal-title":"Food and Chemical Toxicology"},{"key":"10.1016\/j.pharmthera.2019.05.004_bb0610","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbrep.2015.07.011","article-title":"Folate-dependent hydrolysis of acetyl-coenzyme a by recombinant human and rodent arylamine N-acetyltransferases","volume":"3","author":"Stepp","year":"2015","journal-title":"Biochemistry and Biophysics Reports"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.05.004_bb0615","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.canlet.2011.12.022","article-title":"Reduced 4-aminobiphenyl-induced liver tumorigenicity but not DNA damage in arylamine N-acetyltransferase null mice","volume":"318","author":"Sugamori","year":"2012","journal-title":"Cancer Letters"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.05.004_bb0620","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1124\/dmd.107.015396","article-title":"Effect of arylamine acetyltransferase Nat3 gene knockout on N-acetylation in the mouse","volume":"35","author":"Sugamori","year":"2007","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2019.05.004_bb0625","series-title":"Arylamine N-acetlytransfercanse in health and disease","first-page":"231","article-title":"Genetically modified NAT mouse models","author":"Sugamori","year":"2017"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2019.05.004_bb0630","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.0954-6820.1969.tb07309.x","article-title":"Bladder tumours induced by chlornaphazine. A five-year follow-up study of chlornaphazine-treated patients with polycythaemia","volume":"185","author":"Thiede","year":"1969","journal-title":"Acta Medica Scandinavica"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.05.004_bb0635","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017031","article-title":"RNAi-mediated knock-down of arylamine N-acetyltransferase-1 expression induces E-cadherin up-regulation and cell-cell contact growth inhibition","volume":"6","author":"Tiang","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.05.004_bb0640","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bbrc.2010.01.087","article-title":"Small molecule inhibition of arylamine N-acetyltransferase type I inhibits proliferation and invasiveness of MDA-MB-231 breast cancer cells","volume":"393","author":"Tiang","year":"2010","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.05.004_bb0645","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/cam4.415","article-title":"Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines","volume":"4","author":"Tiang","year":"2015","journal-title":"Cancer Medicine"},{"issue":"16","key":"10.1016\/j.pharmthera.2019.05.004_bb0650","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/jnci\/djg025","article-title":"4-aminobiphenyl-induced liver and urinary bladder DNA adduct formation in Cyp1a2(\u2212\/\u2212) and Cyp1a2(+\/+) mice","volume":"95","author":"Tsuneoka","year":"2003","journal-title":"The Journal of the National Cancer Institute"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.05.004_bb0655","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-4165(00)00149-5","article-title":"Placental arylamine N-acetyltransferase type 1: Potential contributory source of urinary folate catabolite p-acetamidobenzoylglutamate during pregnancy","volume":"1524","author":"Upton","year":"2000","journal-title":"Biochimica et Biophysica Acta (BBA) - General Subjects"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.05.004_bb0660","first-page":"346","article-title":"Aromatic amines and cancer","volume":"8","author":"Vineis","year":"1997","journal-title":"Cancer Causes and Control"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.05.004_bb0665","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.bbrc.2007.10.026","article-title":"Deletion of a xenobiotic metabolizing gene in mice affects folate metabolism","volume":"364","author":"Wakefield","year":"2007","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.05.004_bb0670","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193560","article-title":"Arylamine N-acetyltransferase 1 protects against reactive oxygen species during glucose starvation: Role in the regulation of p53 stability","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.05.004_bb0675","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1124\/dmd.115.063297","article-title":"Relative contributions of CYP1A2 and CYP2E1 to the bioactivation and clearance of 4-aminobiphenyl in adult mice","volume":"43","author":"Wang","year":"2015","journal-title":"Drug Metabolism and Disposition"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.05.004_bb0680","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/toxsci\/kfv006","article-title":"N-hydroxylation of 4-aminobiphenyl by CYP2E1 produces oxidative stress in a mouse model of chemically induced liver cancer","volume":"144","author":"Wang","year":"2015","journal-title":"Toxicological Sciences"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.05.004_bb0685","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/em.21695","article-title":"Influence of arylamine N-acetyltransferase, sex, and age on 4-aminobiphenyl-induced in vivo mutant frequencies and spectra in mouse liver","volume":"53","author":"Wang","year":"2012","journal-title":"Environmental and Molecular Mutagenesis."},{"issue":"6","key":"10.1016\/j.pharmthera.2019.05.004_bb0690","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1021\/cen-v044n006.p124","article-title":"Chemicals as causes of cancer","volume":"44","author":"Weisburger","year":"1966","journal-title":"Chemical & Engineering News Archive"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.05.004_bb0695","first-page":"50","article-title":"Monocyclic aromatic amines as potential human carcinogens: Old is new again","volume":"31","author":"Wogan","year":"2009","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.05.004_bb0700","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1158\/1940-6207.CAPR-11-0309","article-title":"Organ specificity of the bladder carcinogen 4-aminobiphenyl in inducing DNA damage and mutation in mice","volume":"5","author":"Yoon","year":"2012","journal-title":"Cancer Prevention Research"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725819300786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725819300786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:00:23Z","timestamp":1759010423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725819300786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":140,"alternative-id":["S0163725819300786"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2019.05.004","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary aromatic amines and cancer: Novel mechanistic insights using 4-aminobiphenyl as a model carcinogen","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2019.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}